GZMA and melanoma: In addition, mice vaccinated with T/O cell-associated OVA and GzmA were protected against the MO4 (OVA-expressing B16 melanoma) tumor (Figure 8D, left), but not against the parental B16 tumor (Figure 8D, right), demonstrating the antigen specific antitumor effect.